Conducting trials abroad has become a strategic move for MedTech and biotech companies looking to optimize budgets. Understanding overseas clinical trials cost is essential, especially as traditional regions like the U.S. and Europe continue to see rising expenses. Why Overseas Clinical Trials Cost Less Regions such as Latin America—particularly Peru—offer significantly lower clinical trial costs compared to Western markets. Studies show that conducting trials in these regions can be 30–40% cheaper than in the U.S. or Europe. Key cost advantages include: Lower labor and site fees Reduced operational and administrative expenses Favorable economic conditions Less competition for clinical trial sites In Peru specifically, average trial expenses are substantially lower while still maintaining high-quality standards. Top Strategies to Reduce Overseas Clinical Trial Costs 1. Optimize Site Selection Choosing high-performing research sites improves efficiency and reduces...

An Investigational Device Exemption (IDE) allows a medical device to be used in a U.S. clinical study before it receives marketing approval from the U.S. Food and Drug Administration . For MedTech innovators, understanding IDE requirements early can significantly impact development timelines, capital efficiency, and regulatory strategy. An IDE is typically required when a device is considered Significant Risk (SR) — including devices that are implantable, life-sustaining, or critical in diagnosing or treating serious disease. Both the Institutional Review Board (IRB) and FDA play important roles in determining risk classification and approving study initiation. The IDE pathway includes a 30-day FDA review clock . Unless the agency places the study on clinical hold, sponsors may begin enrollment after that period. A strong submission must include preclinical testing data, risk analysis, manufacturing information, labeling, and a detailed investigational plan. At bioaccess®, headqu...